Clinical pharmacokinetics of mitoxantrone after intraperitoneal administration
- 1 November 1992
- journal article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 29 (6) , 480-484
- https://doi.org/10.1007/bf00684852
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Phase II trial of intraperitoneal mitoxantrone in the management of refractory ovarian cancer.Journal of Clinical Oncology, 1990
- PHASE-I CLINICAL AND PHARMACOKINETIC STUDY OF MITOXANTRONE GIVEN TO PATIENTS BY INTRAPERITONEAL ADMINISTRATION1988
- HUMAN AUTOPSY TISSUE CONCENTRATIONS OF MITOXANTRONE1986
- Pharmacokinetics of mitoxantrone in humans following single-agent infusion or intra-arterial injection therapy or combined-agent infusion therapyCancer Chemotherapy and Pharmacology, 1986
- The clinical pharmacology of mitozantroneCancer Chemotherapy and Pharmacology, 1986
- In vitro evaluation of anticancer drugs against ovarian cancer at concentrations achievable by intraperitoneal administration.1985
- DISPOSITION OF MITOXANTRONE IN CANCER-PATIENTS1985
- Detection and quantification of mitoxantrone in human organsCancer Chemotherapy and Pharmacology, 1984
- Disposition of mitoxantrone in patientsCancer Treatment Reviews, 1983